Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| R01-06969-21 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Vermont | OTHER |
The purpose of this study is to examine if chronic buprenorphine administration will generate supersensitivity to opiates.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Buprenorphine | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| Drug use | ||
| Opioid agonist effects | ||
| Opiate withdrawal | ||
| Physiological changes in: pupil diameter, blood pressure, heart rate, respiration |
Not provided
Not provided
Please contact site for information.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Warren Bickel, Ph.D. | University of Vermont | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Treatment Research Center | Burlington | Vermont | 05401 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| Background | Bickel, Amass (1995 Experimental & Clinical Psychopharmacology. 3: 477-489 Amass et al 91996) Journal of Substance Abuse Treatment. 13: 43-49 Madden et al., (1997) Experimental & Clinical Psychopharmacology. 5: 1-7. Bickel, Amass (1995) Experimental & Clinical Psychopharmacology. 3: 477-489. Amass et al., (1996) Journal of Substance Abuse Treatment. 13:43-49. Madden et al., (1997) ) Experimental & Clinical Psychopharmacology. 5:1-7. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009293 | Opioid-Related Disorders |
| ID | Term |
|---|---|
| D000079524 | Narcotic-Related Disorders |
| D019966 | Substance-Related Disorders |
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D002047 | Buprenorphine |
| ID | Term |
|---|---|
| D009019 | Morphinans |
| D053610 | Opiate Alkaloids |
| D000470 | Alkaloids |
| D006571 | Heterocyclic Compounds |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| D006572 |
| Heterocyclic Compounds, Bridged-Ring |
| D006576 | Heterocyclic Compounds, 4 or More Rings |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D010616 | Phenanthrenes |
| D011084 | Polycyclic Aromatic Hydrocarbons |
| D011083 | Polycyclic Compounds |